Bristol Royal Hospital for Children, also known as the Bristol Children's Hospital, is a paediatric hospital in Bristol and the only paediatric major trauma centre in South West England. The hospital is part of the University Hospitals Bristol and Weston NHS Foundation Trust, which includes eight other hospitals.

There are 160 beds in Bristol Royal Hospital for Children.

During the past decade, Bristol Royal Hospital for Children conducted 42 clinical trials. In the 10-year time frame, 42 clinical trials started and 17 clinical trials were completed, i.e. on average, 40.5% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 13 clinical trials were completed. i.e. 65% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bristol Royal Hospital for Children" #1 sponsor was "Children's Cancer and Leukaemia Group" with 12 trials, followed by "Eli Lilly and Company" with 5 trials sponsored, "Hoffmann-La Roche" with 5 trials sponsored, "Medical Research Council" with 5 trials sponsored and "Baxalta now part of Shire" with 5 trials sponsored. Other sponsors include 55 different institutions and companies that sponsored additional 46 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bristol Royal Hospital for Children" #1 collaborator was "Baxalta Innovations GmbH, now part of Shire" with 3 trials as a collaborator, "Imperial College London" with 3 trials as a collaborator, "Public Health England" with 2 trials as a collaborator, "Alder Hey Children's NHS Foundation Trust" with 1 trials as a collaborator and "Andaluz Health Service" with 1 trials as a collaborator. Other collaborators include 65 different institutions and companies that were collaborators in the rest 75 trials.

According to Clinical.Site data, the most researched conditions in "Bristol Royal Hospital for Children" are "Brain and Central Nervous System Tumors" (6 trials), "Neuroblastoma" (6 trials), "Juvenile Idiopathic Arthritis" (4 trials), "Sarcoma" (4 trials) and "Hemophilia A" (3 trials). Many other conditions were trialed in "Bristol Royal Hospital for Children" in a lesser frequency.

Most popular intervention types in "Bristol Royal Hospital for Children" are "Drug" (58 trials), "Biological" (22 trials), "Procedure" (13 trials), "Other" (12 trials) and "Radiation" (12 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (11 trials), "carboplatin" (10 trials), "radiation therapy" (10 trials), "Placebo" (9 trials) and "etoposide" (9 trials). Other intervention names were less common.

The vast majority of trials in "Bristol Royal Hospital for Children" are 84 trials for "All" genders, 6 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Bristol Royal Hospital for Children". undefined are not yet recruiting, 14 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 47 completed trials in Bristol Royal Hospital for Children, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Bristol Royal Hospital for Children, 10 "Phase 1" clinical trials were conducted, 33 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 15 trials that are defined as “Not Applicable".